Table 4 Base case and sensitivity analysis results
Parameter | Value | Deaths Averted | Life Years Saved (Millions) | Cost (Savings) (Billions) | Cost Per Life Year Saved |
|---|---|---|---|---|---|
Non-Pandemic | Â | Â | Â | Â | Â |
  Base Case |  | 76714 | 2.50 | 30.67 | 12281 (US$1899) |
Vaccine Coverage | Â | Â | Â | Â | Â |
  Low | 75 % | 76209 | 2.46 | 24.75 | 10072 (US$1558) |
  High | 95 % | 77220 | 2.54 | 36.85 | 14525 (US$2247) |
Vaccine Price | Â | Â | Â | Â | Â |
  Low (-10 %) | 774 | 76714 | 2.50 | 26.40 | 10572 (US$1635) |
  High (+10 %) | 946 | 76714 | 2.50 | 34.94 | 13991 (US$2164) |
Herd Effect | Â | Â | Â | Â | Â |
  Reduced by 50 % |  | 41195 | 1.47 | 36.17 | 24549 (US$3797) |
Disease Incidence | Â | Â | Â | Â | Â |
  Low (-10 %) |  | 69167 | 2.25 | 31.90 | 14158 (US$2190) |
  High (+10 %) |  | 84524 | 2.75 | 29.40 | 10676 (US$1651) |
Case Fatality Rate | Â | Â | Â | Â | Â |
  Low (-10 %) |  | 69063 | 2.25 | 30.67 | 13640 (US$2109) |
  High (+10 %) |  | 84411 | 2.75 | 30.67 | 11160 (US$1726) |
Pandemic | Â | Â | Â | Â | Â |
  Base Case |  | 707526 | 34.43 | (41.03) | Dominant |
Vaccine Coverage | Â | Â | Â | Â | Â |
  Low | 75 % | 702582 | 34.03 | (46.88) | Dominant |
  High | 95 % | 712470 | 34.82 | (34.93) | Dominant |
Vaccine Price | Â | Â | Â | Â | Â |
  Low (-10 %) | 774 | 707526 | 34.43 | (45.30) | Dominant |
  High (+10 %) | 946 | 707526 | 34.43 | (36.76) | Dominant |
Herd Effect | Â | Â | Â | Â | Â |
  Reduced by 50 % |  | 384613 | 19.65 | (0.48) | Dominant |
Disease Incidence | Â | Â | Â | Â | Â |
  Low (-10 %) |  | 641668 | 31.23 | (33.21) | Dominant |
  High (+10 %) |  | 782365 | 38.09 | (50.06) | Dominant |
Case Fatality Rate | Â | Â | Â | Â | Â |
  Low (-10 %) |  | 637577 | 31.02 | (41.03) | Dominant |
  High (+10 %) |  | 779261 | 37.92 | (41.03) | Dominant |